Transcatheter arterial infusion therapy in the treatment of advanced pancreatic cancer: A feasibility study
作者： Keiko Shibuya , Yasushi Nagata , Tuyoshi Itoh , Kaoru Okajima , Rumi Murata
关键词:
摘要: Purpose: To evaluate the effects of transcatheter arterial infusion (TAI) therapy in 18 patients with advanced pancreatic cancer. Methods: The drugs infused were epirubicin 60 mg, mitomycin C 20 and 5-fluorouracil 500 mg. efficacy TAI was evaluated by a tumor marker (CA19-9), computed tomography (CT) findings, postoperative histopathological specimens. Results: In 10 15 cases, level decreased after therapy. 6 14 CT showed decrease size, 1 case, disappeared completely. cases could be resected. Necrosis, fibrosis, degeneration cancer cells seen 3 4 for whom evaluation done. median survival 11 months. 17 back pain chief complaint, reduced to self-controlled following No major complications encountered. Conclusion: appears an effective palliative treatment
springer.com
osti.gov
sci-hub.se 参考文章(20)
Susan G. Arbuck, Susan G. Arbuck, Overview of chemotherapy for pancreatic cancer. International Journal of Pancreatology. ,vol. 7, pp. 209- 222 ,(1990) , 10.1007/BF02924239
F. P. Gall, F. Kückerling, The Problem of Radical Surgery in Pancreatic Cancer and Its Implications for a Combined- Treatment Approach Combined Modality Therapy of Gastrointestinal Tract Cancer. ,vol. 110, pp. 79- 86 ,(1988) , 10.1007/978-3-642-83293-2_11
Kita M, Okawa T, [Clinical evaluation of implantable drug delivery system (Port-A-Cath) in cancer chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy. ,vol. 15, pp. 2659- ,(1988)
V D Courtenay, J Mills, G G Steel, The spectrum of chemosensitivity of two human pancreatic carcinoma xenografts British Journal of Cancer. ,vol. 46, pp. 436- 439 ,(1982) , 10.1038/BJC.1982.221
Frederick P. Smith, Daniel F. Hoth, Bernard Levin, David A. Karlin, John S. Macdonald, Paul V. Woolley, Philip S. Schein, 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas Cancer. ,vol. 46, pp. 2014- 2018 ,(1980) , 10.1002/1097-0142(19801101)46:9<2014::AID-CNCR2820460920>3.0.CO;2-D
James H. Muchmore, Janet E. Preslan, William J. George, Regional chemotherapy for inoperable pancreatic carcinoma. Cancer. ,vol. 78, pp. 664- 673 ,(1996) , 10.1002/(SICI)1097-0142(19960801)78:3<664::AID-CNCR47>3.0.CO;2-U
John F. Griffin, Stephen R. Smalley, William Jewell, Jorge C. Paradelo, Ralph D. Reymond, Ruth E. S. Hassanein, Richard G. Evans, Patterns of failure after curative resection of pancreatic carcinoma Cancer. ,vol. 66, pp. 56- 61 ,(1990) , 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6
R. M. Bukowski, L. P. Schacter, C. W. Groppe, J. S. Hewlett, J. K. Weick, R. B. Livingston, Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma Cancer. ,vol. 50, pp. 197- 200 ,(1982) , 10.1002/1097-0142(19820715)50:2<197::AID-CNCR2820500204>3.0.CO;2-N
James H. Muchmore, Treatment of advanced pancreatic cancer with regional chemotherapy plus hemofiltration Seminars in Surgical Oncology. ,vol. 11, pp. 154- 167 ,(1995) , 10.1002/SSU.2980110213
Seiki Matsuno, Hirotake Hisano, Masao Kobari, Satoshi Akaishi, Growth-inhibitory effects of combination chemotherapy for human pancreatic cancer cell lines Cancer. ,vol. 66, pp. 2369- 2374 ,(1990) , 10.1002/1097-0142(19901201)66:11<2369::AID-CNCR2820661120>3.0.CO;2-Z